Galapagos Biotech Ltd

• 2023 CARDIOVASCULAR (CV) AND MALIGNANCY EVENTS IN THE FILGOTINIB (FIL) RHEUMATOID ARTHRITIS (RA) CLINICAL DEVELOPMENT PROGRAM UP TO 8.3 YEARS

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format